Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-release (ER) for Hypertension
Tolerability of Nebivolol Compared With Metoprolol ER in Patients With Mild to Moderate Hypertension Taking Hydrochlorothiazide (HCTZ)
Sponsor: Forest Laboratories
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Forest Laboratories
A PHASE3 clinical study on Hypertension, this trial is terminated or withdrawn. The trial is conducted by Forest Laboratories and has accumulated 7 data snapshots since 2007. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE3
-
Jun 2019 — Jan 2021 [monthly]
Terminated PHASE3
Status: Completed → Terminated
▶ Show 2 earlier versions
-
Jun 2018 — Jun 2019 [monthly]
Completed PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Oct 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Forest Laboratories
- Mylan Laboratories
For direct contact, visit the study record on ClinicalTrials.gov .